GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » Current Ratio

Invitro International (Invitro International) Current Ratio : 4.44 (As of Jun. 2097)


View and export this data going back to 1991. Start your Free Trial

What is Invitro International Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Invitro International's current ratio for the quarter that ended in Jun. 2097 was 4.44.

Invitro International has a current ratio of 4.44. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for Invitro International's Current Ratio or its related term are showing as below:

IVRO's Current Ratio is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.03
* Ranked among companies with meaningful Current Ratio only.

Invitro International Current Ratio Historical Data

The historical data trend for Invitro International's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitro International Current Ratio Chart

Invitro International Annual Data
Trend Feb90 Feb91 Sep92 Sep93 Sep94 Sep95 Sep96
Current Ratio
Get a 7-Day Free Trial 0.91 5.38 6.33 6.50 5.00

Invitro International Quarterly Data
Sep92 Dec92 Mar93 Jun93 Sep93 Dec93 Mar94 Jun94 Sep94 Dec94 Mar95 Jun95 Sep95 Dec95 Mar96 Jun96 Sep96 Dec96 Mar97 Jun97
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.75 5.00 - 4.20 4.44

Competitive Comparison of Invitro International's Current Ratio

For the Diagnostics & Research subindustry, Invitro International's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invitro International's Current Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's Current Ratio distribution charts can be found below:

* The bar in red indicates where Invitro International's Current Ratio falls into.



Invitro International Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Invitro International's Current Ratio for the fiscal year that ended in Sep. 2096 is calculated as

Current Ratio (A: Sep. 2096 )=Total Current Assets (A: Sep. 2096 )/Total Current Liabilities (A: Sep. 2096 )
=2/0.4
=5.00

Invitro International's Current Ratio for the quarter that ended in Jun. 2097 is calculated as

Current Ratio (Q: Jun. 2097 )=Total Current Assets (Q: Jun. 2097 )/Total Current Liabilities (Q: Jun. 2097 )
=0.857/0.193
=4.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invitro International  (OTCPK:IVRO) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Invitro International Current Ratio Related Terms

Thank you for viewing the detailed overview of Invitro International's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Invitro International (Invitro International) Business Description

Traded in Other Exchanges
N/A
Address
330 East Orangethorpe Avenue, Suite D, Placentia, CA, USA, 92870
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.